AMANY DIGAL LADAGU

AMANY DIGAL LADAGU

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AMANY DIGAL LADAGUAMANY DIGAL LADAGU
AMANY DIGAL LADAGU
FOFunmilayo Eniola Olopade
Funmilayo Eniola Olopade
HLHoa T. T Le
Hoa T. T Le
JOJames Olukayode Olopade
James Olukayode Olopade
N-methyl-D-aspartate receptors (NMDARs) are ion channels that respond to the neurotransmitter glutamate, playing a crucial role in the permeability of calcium ions and excitatory neurotransmission in the central nervous system (CNS). Composed of various subunits, NMDARs are predominantly formed by two obligatory GluN1 subunits (with eight splice variants) along with regulatory subunits GluN2 (GluN2A-2D) and GluN3 (GluN3A-B). They are widely distributed throughout the CNS and are involved in essential functions such as synaptic transmission, learning, memory, plasticity, and excitotoxicity. The presence of GluN2A and GluN2B subunits is particularly important for cognitive processes and has been strongly implicated in neurodegenerative diseases like Parkinson’s disease and Alzheimer’s disease. Understanding the roles of GluN2A and GluN2B NMDARs in neuropathologies provides valuable insights into the underlying causes and complexities of major nervous system disorders. This knowledge is vital for the development of selective antagonists targeting GluN2A and GluN2B subunits using pharmacological and molecular methods. Such antagonists represent a promising class of NMDA receptor inhibitors that have the potential to be developed into neuroprotective drugs with optimal therapeutic profiles.

Verified
Journal Article
Open access
PDF file
SOSamuel Ohiomokhare
Samuel Ohiomokhare
FOFrancis Abiodun Olaolorun
Francis Abiodun Olaolorun
AMANY DIGAL LADAGUAMANY DIGAL LADAGU
AMANY DIGAL LADAGU
FOFunmilayo Eniola Olopade
Funmilayo Eniola Olopade
MHMelanie-Jayne R Howes
Melanie-Jayne R Howes
Paul ChazotPaul Chazot
Paul Chazot
Parkinson’s disease (PD) pathology is characterised by distinct types of cellular defects, notably associated with oxidative damage and mitochondria dysfunction, leading to the selective loss of dopaminergic neurons in the brain’s substantia nigra pars compacta (SNpc). Exposure to some environmental toxicants and heavy metals has been associated with PD pathogenesis. Raised iron levels have also been consistently observed in the nigrostriatal pathway of PD cases. This study explored, for the first time, the effects of an exogenous environmental heavy metal (vanadium) and its interaction with iron, focusing on the subtoxic effects of these metals on PD-like oxidative stress phenotypes in Catecholaminergic a-differentiated (CAD) cells and PTEN-induced kinase 1 (PINK−1)B9Drosophila melanogaster models of PD. We found that undifferentiated CAD cells were more susceptible to vanadium exposure than differentiated cells, and this susceptibility was modulated by iron. In PINK−1 flies, the exposure to chronic low doses of vanadium exacerbated the existing motor deficits, reduced survival, and increased the production of reactive oxygen species (ROS). Both Aloysia citrodora Paláu, a natural iron chelator, and Deferoxamine Mesylate (DFO), a synthetic iron chelator, significantly protected against the PD-like phenotypes in both models. These results favour the case for iron-chelation therapy as a viable option for the symptomatic treatment of PD.

30 May 2023 in Nigerian Journal of Physiological Sciences
Verified
Journal Article
Open access
PDF file
TGTaidinda Gilbert
Taidinda Gilbert
FOFrancis Abiodun Olaolorun
Francis Abiodun Olaolorun
AMANY DIGAL LADAGUAMANY DIGAL LADAGU
AMANY DIGAL LADAGU
FOFunmilayo Eniola Olopade
Funmilayo Eniola Olopade
OIOlumayowa O. Igado
Olumayowa O. Igado
JOJames Olukayode Olopade
James Olukayode Olopade
Vanadium is a ubiquitous transition metal that has been generating contrasting research interest. Therapeutically, vanadium possess antidiabetic, antitumor, antiparasitic and even neuroprotective activities. On the flip side, vanadium has been reported to cause multisystemic toxicities with a strong predilection for the nervous system. Despite several reports on potential benefits of low-dose vanadium (LDV) and toxic effects of high-dose vanadium (HDV), there are no comparative studies done thus far. This study therefore explored the comparative effects of LDV and HDV exposure in mice during postnatal development. A total of nine (9) nursing mice were used in this study; with three nursing mice and their pups (n = 12 pups per group) randomly assigned to each of the three test groups. The nursing dam were given intraperitoneal (i.p) injection of vanadium at 0.15mg/kg and 3mg/kg for LDV and HDV respectively, and subseqently to the pups from postnatal day (PND) 15 till sacrifice on PND 90. We discovered that neurodevelopmental motor function test of mice-pups exposed to LDV here showed improved motor development, muscular strength and memory capacities whereas HDV led to motor function impairment, reduced muscular strength and memory capacities. LDV-exposed mice showed mild histological lesions in cerebral cortex whereas high-dose showed distinct histological lesions in different parts of the brain ranging from cerebellar Purkinje neuronal pathology (central chromatolysis), pyramidal neuronal loss in CA1 region, architectural distortion as well as fewer neurons in olfactory bulb. We saw mild lesions with LDV in both liver and kidney, however, with HDV exposure, there was diffuse hepatocellular vacuolar degeneration and congestion of blood vessels in liver, shrinkage of renal glomerulus and degenerated epithelial cells of kidney. Conclusively, beneficial effect of vanadium is proven as it facilitated body weight gain which translate in organ weight at low-dose, while high-dose caused decreased neurobehaviour and histological lesions.

1 July 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ZFZemo Gamo Franklin
Zemo Gamo Franklin
AMANY DIGAL LADAGUAMANY DIGAL LADAGU
AMANY DIGAL LADAGU
KMKetcha Wanda Germain Jean Magloire
Ketcha Wanda Germain Jean Magloire
OFOluwabusayo Racheal Folarin
Oluwabusayo Racheal Folarin
SDSefirin Nange DJIOGUE
Sefirin Nange DJIOGUE
JOJames Olukayode Olopade
James Olukayode Olopade

Verified
Journal Article
Open access
PDF file
AMANY DIGAL LADAGUAMANY DIGAL LADAGU
AMANY DIGAL LADAGU
FOFunmilayo Eniola Olopade
Funmilayo Eniola Olopade
Paul ChazotPaul Chazot
Paul Chazot
AOAdemola Oyagbemi
Ademola Oyagbemi
SOSamuel Ohiomokhare
Samuel Ohiomokhare
JOJames Olukayode Olopade
James Olukayode Olopade
Exposure to heavy metals, such as vanadium, poses an ongoing environmental and health threat, heightening the risk of neurodegenerative disorders. While several compounds have shown promise in mitigating vanadium toxicity, their efficacy is limited. Effective strategies involve targeting specific subunits of the NMDA receptor, a glutamate receptor linked to neurodegenerative conditions. The potential neuroprotective effects of ZA-II-05, an NMDA receptor antagonist, against vanadium-induced neurotoxicity were explored in this study. Organotypic rat hippocampal slices, and live mice, were used as models to comprehensively evaluate the compound’s impact. Targeted in vivo fluorescence analyses of the hippocampal slices using propidium iodide as a marker for cell death was utilized. The in vivo study involved five dams, each with eight pups, which were randomly assigned to five experimental groups (n = 8 pups). After administering treatments intraperitoneally over six months, various brain regions were assessed for neuropathologies using different immunohistochemical markers. High fluorescence intensity was observed in the hippocampal slices treated with vanadium, signifying cell death. Vanadium-exposed mice exhibited demyelination, microgliosis, and neuronal cell loss. Significantly, treatment with ZA-II-05 resulted in reduced cellular death in the rat hippocampal slices and preserved cellular integrity and morphological architecture in different anatomical regions, suggesting its potential in countering vanadium-induced neurotoxicity.